AMBU A/S Launch of Long-Term Incentive Plan
In accordance with the Remuneration Policy approved at the annual general meeting on 17 December 2019, Ambu A/S has today launched a long-term incentive plan for the Executive Board. In addition, 186 key employees in the global organisation are enrolled in the plan on similar terms. In the plan, the Executive Board receives a total of up to 66,410 Performance Share Units (PSUs) while key employees receive a total of up to 139.266 PSUs. Each PSU may at vesting
- on 1 January 2024 - be converted to one B share in Ambu A/S subject to the terms of the program.
The plan covers the financial year 2020/21, and the PSUs will be allocated based on how targets for organic revenue growth for 2020/21 are achieved. Final allocation will be within 0-100% of the grant. The aggregate fair market value of the total allocation at the time of grant equals DKK 43m.
Depending on the future development of the share price of the Ambu B share, the value of the PSUs will, at the time of vesting, be capped at four times the annual base salary measured at the time of the grant.
The share price used for calculating the number of PSUs has, in accordance with the policy, been the day of the annual general meeting in Ambu A/S in December 2020 and the following four trading days (9-15 December 2020).
Contacts
Investors
Nicolai Thomsen, Director, Investor Relations, nith@ambu.com / +45 2620 8047
Media
Mikkel Trier Wagner, Director, Corporate Communications, mtw@ambu.com / +45 4191 0830
Ambu A/S, Baltorpbakken 13, DK-2750 Ballerup, Denmark, Tel.: +45 7225 2000, CVR no.: 63 64 49 19, www.ambu.com
About Ambu
Ambu has been bringing the solutions of the future to life since 1937. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety and performance of our single-use endoscopy, anaesthesia, and patient monitoring & diagnostics solutions. The manifestations of our efforts have ranged from early innovations like the Ambu® Bag™ resuscitator and the Ambu® BlueSensor™ electrodes to our newest landmark solutions like the Ambu® aScope™ - the world's first single-use flexible endoscope. Moreover, we continuously look to the future with a commitment to deliver innovative quality products that have a positive impact on the work of doctors, nurses and paramedics. Headquartered near Copenhagen in Denmark, Ambu employs approximately 4,000 people in Europe, North America and the Asia Pacific. For more information, please visit ambu.com
Ambu | ||
Company announcement no. 10 2020/21 | 29 January 2021 | Page 1 |
Attachments
- Original document
- Permalink
Disclaimer
Ambu A/S published this content on 29 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 January 2021 15:01:02 UTC.
